|
Top Drugs: Top Synthetic Routes is #90 in the Oxford Chemistry Primer
series. According to the editor, Stephen G. Davies, books in this series “…have
been designed to provide concise introductions relevant to all students of chemistry
and contain only the essential material that would normally be covered in an 8–10
lecture course.” As the title suggests this member of the series is designed
to explore synthetic routes to a number of important drugs.
All of the compounds considered are or have been drugs used to treat human
diseases. Thirty-six different drugs are grouped into 10 chapters organized according
to classes of human disease treated: cardiovascular, gastrointestinal, and central
nervous system problems as well as inflammatory and infectious diseases. Drugs
investigated include captopril (hypertension), losartan (hypertension), nifedipine
(angina), cimetidine (ulcers), omeprazole (antacid), fluoxetine (depression),
diazepam (muscle relaxant), terfenadine (seasonal allergic rhinitis), zidovudine
(AZT HIV), and norfloxacin (antibacterial).
In the introduction, the author states, “Individual chapters are focused
on collections of drugs that operate via the same mechanism. After an introduction
to the discovery and mechanism of action, each drug is discussed in terms of its
first synthesis and then later routes which have points of interest to organic
chemists.” The author’s description is accurate. Each chapter provides
a short history of the medical target (e.g., depression) as well as the logic
for the original choice of potential drugs in terms of their physiological mechanism
of action. These historical discussions provide valuable insight into the metabolic
processes involved in the target disease. This material is likely to be beyond
the experience of typical synthetic organic chemistry students.
Following the chapter introduction, between two and five separate drugs are
presented. For each drug, an early successful synthesis is briefly outlined with
a scheme illustrating structures of each isolable intermediate and one or more
literature references. The author then identifies subsequent modifications of
the original synthesis, explaining the goal and logic of the modification. Although
the author provides a step-by-step presentation of the original synthesis, he
does not explain the logic that led to the particular synthetic route. Starting
materials are presented as given with no indication of how they were chosen. Then
reagents for each step are provided but no suggestion of why the particular reagents
were chosen. Readers interested in the synthetic logic of the original syntheses
will need to consult the references provided. Unfortunately, several of the references
are to patents, which generally provide little in the way of the reasoning used
in devising particular synthetic paths.
The considerations of modifications of original procedures provide insight
into the problems with original syntheses and approaches to improving them, particularly
with respect to asymmetric synthetic approaches. However, the particular improvements
are again presented in a matter-of-fact manner with minimal consideration of why
the particular process was chosen.
On the whole, Top Drugs: Top Synthetic Routes provides valuable insight
into the metabolic bases for rational drug design and some ways that existing
syntheses may be modified to improve specific characteristics of the product.
However, it does not deal significantly with the logic of synthetic design. Thus,
this book may be of use to synthetic organic chemists accomplished in devising
synthetic paths to desired target molecules, yet in need of more insight into
the rational choice of target molecules. It will not be of very much use to students
hoping to gain insight into the logic of synthetic design.
|